A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ES / endostatin

[Related PubMed/MEDLINE]
Total Number of Papers: 106
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ES  (>> Co-occurring Abbreviation)
Long Form:   endostatin
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Functional Impact of Human Genetic Variants of Collagen 18A1/Endostatin on Pulmonary Endothelium. Col18a1, PAH, PEC, TSP-1
2019 Characterization, bioactivity and pharmacokinetic study of a novel carbohydrate-peptide polymer: Glycol-split heparin-endostatin2 (GSHP-ES2). GSHP-ES2, GSHPs
2019 Clinical observation of the reduced glutathione in the treatment of diabetic chronic kidney disease. AOPP, CKD, MDA, NK, OS, SOD, VEGF
2019 Hexokinase2 controls angiogenesis in melanoma by promoting aerobic glycolysis and activating the p38-MAPK signaling. HK2, HK2shRNA1, MAPK
2019 Inhibition of constructed SEC3-ES lentiviral vector to proliferation, migration of Hela cells. SEC3
2019 Serum endostatin level as a marker for coronary artery calcification in type 2 diabetic patients. ASI, AUC, CAC, CAD, CI, CT, hs-CRP, OR, ROC
2018 Higher Anti-angiogenesis Activity, Better Cellular Uptake and Longer Half-life of a Novel Glyco-modified Endostatin by Polysulfated Heparin. AUC, PSH
2018 Impact of endostatin gene therapy on myeloid-derived suppressor cells from a metastatic renal cell carcinoma. G-CSF, MDSC, mRCC, RCC, ROS
2018 MIG7 is involved in vasculogenic mimicry formation rendering invasion and metastasis in hepatocellular carcinoma. HCC, MIG7, VM
10  2017 Correlation of Plasma Vascular Endothelial Growth Factor and Endostatin Levels with Symptomatic Intra- and Extracranial Atherosclerotic Stenosis in a Chinese Han Population. ECAS, ICAS, LAA, VEGF
11  2017 Delisheng induces antiproliferation and apoptosis effects in Hep3B cells via modulation of angiogenic proteins. HCC, OPN, VEGF
12  2017 Endostatin inhibits androgen-independent prostate cancer growth by suppressing nuclear receptor-mediated oxidative stress. AR, GR, PCa, ROS
13  2017 Structural studies of the protein endostatin in fusion with BAX BH3 death domain, a hybrid that presents enhanced antitumoral activity. ---
14  2017 Unexpected and striking effect of heparin-free dialysis on cytokine release. ACTA, HD, MCP-1
15  2016 Antitumor activity of combined endostatin and thymidine kinase gene therapy in C6 glioma models. GCV, HSV-TK, HUVECs, IRES, MVD
16  2016 Comparisons of biophysical properties and bioactivities of mono-PEGylated endostatin and an endostatin analog. GdmCl, MZBP-ES, ZBP-ES
17  2016 Effects of caffeic acid phenethyl ester on matrix molecules and angiogenetic and anti-angiogenetic factors in gastric cancer cells cultured on different substrates. MMP-9, MTT, TSP-1, VEGF
18  2016 Endostatin and irradiation modifies the activity of ADAM10 and neprilysin in breast cancer cells. ADAM10, NEP, RT
19  2016 Endostatin gene therapy inhibits intratumoral macrophage M2 polarization. RCC, TAMs
20  2016 Endostatin is protective against monocrotaline-induced right heart disease through the inhibition of T-type Ca(2+) channel. MCT, RVs, siRNA
21  2016 Endothelial Progenitor Cells Combined with Cytosine Deaminase-Endostatin for Suppression of Liver Carcinoma. CD, EPCs, SPIO
22  2016 Multi-scale mathematical modelling of tumour growth and microenvironments in anti-angiogenic therapy. ---
23  2016 Physical inactivity increases endostatin and osteopontin in patients with coronary artery disease. CAD, OPN
24  2016 [Inhibitory effect of Mig-7 silencing by retrovirus-mediated shRNA on vasculogenic mimicry, invasion and metastasis of human hepatocellular carcinoma cells in vitro]. HCC, Mig-7, shRNA, VM
25  2016 [Inhibitory effect of migration-inducing gene-7-shRNA recombinant retrovirus combined with endostatin on growth and metastasis of hepatoma xenograft]. HCC, Mig-7, MVD, VEGF, VM
26  2015 Augmented anti-angiogenesis activity of polysulfated heparin-endostatin and polyethylene glycol-endostatin in alkali burn-induced corneal ulcers in rabbits. CNV, PEG-ES, PSH-ES
27  2015 Basic fibroblast growth factor shows prognostic impact on survival in operable non-small cell lung cancer patients. bFGF, CI, HR, NSCLC, OS, VEGF
28  2015 Hypoxia and TGF-beta1 lead to endostatin resistance by cooperatively increasing cancer stem cells in A549 transplantation tumors. CSCs, MDSCs, TGF
29  2015 Inhibitory effect of polysulfated heparin endostatin on alkali burn induced corneal neovascularization in rabbits. NV, PSH-ES, VEGF
30  2015 Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension. PAH, RV
31  2014 Endostatin and Thrombospondin-1 levels are increased in the sera of patients with chronic spontaneous urticaria. ASST, CSU, CU, ECM, TSP-1, VEGF
32  2014 Improving the therapeutic potential of endostatin by fusing it with the BAX BH3 death domain. ---
33  2014 Involvement of the NF-кB/p50/Bcl-3 complex in response to antiangiogenic therapy in a mouse model of metastatic renal cell carcinoma. EMSA, RCC
34  2014 Recombinant human endostatin combined with radiotherapy in the treatment of brain metastases of non-small cell lung cancer. BM, VEGFR2
35  2014 Soluble ST2 and N-terminal pro-brain natriuretic peptide combination. Useful biomarker for predicting outcome of childhoodpulmonary arterial hypertension. Ang-2, HPAH, IPAH, NT-proBNP, PAH, sST2
36  2014 Study of an antiangiogenesis gene therapy with endostatin on endometriosis in the nude mouse model. EMS, MVD
37  2013 C-X-C motif receptor 2, endostatin and proteinase-activated receptor 1 polymorphisms as prognostic factors in NSCLC. CXCR2, DFS, IL-8, NSCLC, OS, PAR-1, PCR
38  2013 Genetically engineered endostatin-lidamycin fusion proteins effectively inhibit tumor growth and metastasis. AE, ES-LDM, ES-LDP, LDM, LDP-ES
39  2013 The effect of intracellular protein delivery on the anti-tumor activity of recombinant human endostatin. MTD
40  2013 Vascular endothelial growth factor as a biomarker for endostatin gene therapy. mRCC, RCC, VEGF
41  2013 VEGFR-2, CXCR-2 and PAR-1 germline polymorphisms as predictors of survival in pancreatic carcinoma. CXCR2, DFS, OS, PAR-1, PC, VEGFR2
42  2012 Clinical predictive value of serum angiogenic factor in patients with osteosarcoma. bFGF, MVD, TGF-beta1, VEGF
43  2012 Endostatin gene therapy stimulates upregulation of ICAM-1 and VCAM-1 in a metastatic renal cell carcinoma model. ICAM-1, IFN, mRCC, RCC, VCAM-1
44  2012 Endostatin lowers blood pressure via nitric oxide and prevents hypertension associated with VEGF inhibition. ---
45  2012 Endostatin neoadjuvant gene therapy extends survival in an orthotopic metastatic mouse model of renal cell carcinoma. RCC
46  2012 Enhanced anti-angiogenesis and anti-tumor activity of endostatin by chemical modification with polyethylene glycol and low molecular weight heparin. CAM, CNV, LMWH, PEG
47  2012 Evaluation of serum and pleural levels of endostatin and vascular epithelial growth factor in lung cancer patients with pleural effusion. CEA, VEGF
48  2012 Fibronectin expression is decreased in metastatic renal cell carcinoma following endostatin gene therapy. FN, mRCC, RCC
49  2012 Functional role of T-type calcium channels in tumour growth and progression: prospective in cancer therapy. ---
50  2012 Inhibition of T-type Ca⁺ channels by endostatin attenuates human glioblastoma cell proliferation and migration. T-currents
51  2012 Preparation, characterization and anti-angiogenesis activity of endostatin covalently modified by polysulfated heparin. CAM, CD, CNV, PEDF, PSH, VEGF
52  2012 Unexpected properties of endostatin-producing mouse BCR-ABL-transformed cells. i.v
53  2012 [Chinese herbal decoction Shiquan Dabu Tang inhibits tumor growth and angiogenesis of metastasis after primary tumor surgical removal in mice]. AS, ELISA, MVD, SDT, TP, TR, TUNEL, VEGF
54  2011 Circulating levels of angiogenic cytokines in advanced breast cancer patients with system chemotherapy and their potential value in monitoring disease course. VEGF
55  2011 Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium derived factor make low molecular weight heparin-endostatin and polyethylene glycol-endostatin potential candidates for anti-angiogenesis drug. LMWH-ES, PEDF, PEG-ES, VEGF
56  2011 Effect of peritoneal dialysis on expression of vascular endothelial growth factor, basic fibroblast growth factor and endostatin of the peritoneum in peritoneal dialysis patients. bFGF, MVD, PD, VEGF
57  2011 Endostatin enhances radioresponse in breast cancer cells via alteration of substance P levels. RT
58  2011 Endostatin- and interleukin-2-expressing retroviral bicistronic vector for gene therapy of metastatic renal cell carcinoma. IFN, IL, mRCC
59  2011 [Correlation between the ratio of serum vascular endothelial growth factor/endostatin and childhood acute leukemia]. AL, VEGF
60  2010 Continuous and high-level in vivo delivery of endostatin from recombinant cells encapsulated in TheraCyte immunoisolation devices. PTFE
61  2010 Endostatin binds nerve growth factor and thereby inhibits neurite outgrowth and neuronal migration in-vitro. NGF
62  2010 Endostatin expression in neurons during the early stage of cerebral ischemia is associated with neuronal apoptotic cell death in adult hypertensive rat model of stroke. AMC, CB, dMCAO, IR
63  2010 Erythrocyte protoporphyrin fluorescence as a biomarker for monitoring antiangiogenic cancer therapy. mRCC, MVA, RCC
64  2010 Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma. IL-8, OS, PAR, TTR
65  2010 Immobilized kidney 28-kDa endostatin-related (KES28kDa) fragment promotes endothelial cell survival. AKI
66  2010 Urinary angiostatin levels are elevated in patients with epithelial ovarian cancer. AS, EOC, HGF, PP, uAS, VEGF
67  2010 [Contribution to the evaluation of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and in individual clinical stages of multiple myeloma]. beta 2m, DS, IMWG, ISS, MGUS, MM
68  2009 Anti-angiogenic factor endostatin in osteosarcoma. OSAs
69  2009 Endostatin derivative angiogenesis inhibitors. LMWH, PEG
70  2009 High plasma endostatin level unaffected by low-molecular weight heparin in hemodialysis patients--a preliminary report. HD
71  2009 Ischemia-reperfusion injury activates early extracellular matrix processing and expression of endostatin in the heart with differential effects of temperature. ECM
72  2009 [Dynamic study on effect of Chinese medicine compound Yiliuyin on angiogenesis in transplanted S180 tumor of mouse]. PED, VEGF, VEGFR2, YLY
73  2009 [Effects of endostatin on the expression of Tubulinbeta mRNA in the retina of oxygen-induced retinal neovascularization]. ---
74  2009 [Pathological basis of qi-deficiency and blood stasis syndrome in patients with non-small cell lung cancer viewing from tumor metastasis related factors]. NSCLC, QDBS, slCAM-1, TMRF, VEGF
75  2009 [The Effect of Endostatin and Radiotherapy on Human Lung Cancer Cell Line A549 and the Impact of HIF-1 Expression after Therapy.]. MTT, RT
76  2008 Characterization and secondary structure analysis of endostatin covalently modified by polyethylene glycol and low molecular weight heparin. LMWH, SFDA
77  2008 Refolding of endostatin from inclusion bodies using high hydrostatic pressure. IBs
78  2008 Voltage-dependent anion channel 1 is involved in endostatin-induced endothelial cell apoptosis. HK2, HMECs, mPTP, VDAC1
79  2007 A gene transfer comparative study of HSA-conjugated antiangiogenic factors in a transgenic mouse model of metastatic ocular cancer. ATF, HSA
80  2007 Anti-tumor effect of endostatin mediated by retroviral gene transfer in mice bearing renal cell carcinoma. ---
81  2007 [Clinical and prognostic significance of serum MMP-9, endostatin and VEGF in patients with advanced non-small cell lung cancer]. MMP-9, NSCLC, VEGF
82  2007 [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer]. ---
83  2006 Endostatin, the proteolytic fragment of collagen XVIII, induces vasorelaxation. eNOS, fura-2 AM, NO
84  2006 Moderate antiangiogenic activity by local, transgenic expression of endostatin in Rip1Tag2 transgenic mice. Rip1, Tag2
85  2006 [Effects of norcantharidin on angiogenesis of human gallbladder carcinoma and its anti-angiogenic mechanisms]. 5-FU, Ang, MVD, NCTD, NS, PCNA, TIMP, TSP, VEGF
86  2006 [Fusion expression and identification of angiostatin and endostatin in E. coli BL21(DE3)]. AS
87  2006 [Transfer of endostatin gene for inhibition of retinal angiogenesis in mice]. ---
88  2005 Antiangiogenic treatment with endostatin inhibits progression of AML in vivo. ---
89  2005 Endostatin binds biglycan and LDL and interferes with LDL retention to the subendothelial matrix during atherosclerosis. SEM
90  2005 Endostatin induces acute endothelial nitric oxide and prostacyclin release. BAECs, EC, eNOS, NO
91  2005 Endostatin inhibits nitric oxide and diminishes VEGF and collagen XVIII in squamous carcinoma cells. AG, DPI, NO, SCC, VEGF
92  2005 Imbalance in the production between vascular endothelial growth factor and endostatin in Kawasaki disease. KD, VEGF
93  2005 [Inhibition of corneal neovascularization by liposomes mediated plasmid encoding human endostatin]. CNV
94  2005 [Study on the role of angiogenesis and related factors in leukemias]. AL, CML, CR, FCM, HP, MVD, VEGF
95  2004 Inhibition of cytokine-induced microvascular arrest of tumor cells by recombinant endostatin prevents experimental hepatic melanoma metastasis. B16M, HSE, IL-18, rh, TNF-alpha, VEGF
96  2004 [Liposomes mediated plasmids encoding human endostatin inhibits endothelial cell proliferation]. MTT
97  2002 Endostatin is a potential inhibitor of Wnt signaling. TCF
98  2002 Inhibitors of angiogenesis selectively reduce the malignant cell load in rodent models of human myeloid leukemias. JMML
99  2002 Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function. FGF, HS, SAS-domain
100  2002 The combination of HSV-tk and endostatin gene therapy eradicates orthotopic human renal cell carcinomas in nude mice. HSV-TK, RCC